Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial.

Fiocca R, Mastracci L, Attwood SE, Ell C, Galmiche JP, Hatlebakk J, Bärthel A, Långström G, Lind T, Lundell L; LOTUS trial collaborators..

Aliment Pharmacol Ther. 2012 Nov;36(10):959-71. doi: 10.1111/apt.12052. Epub 2012 Sep 23.

2.

Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial.

Galmiche JP, Hatlebakk J, Attwood S, Ell C, Fiocca R, Eklund S, Långström G, Lind T, Lundell L; LOTUS Trial Collaborators..

JAMA. 2011 May 18;305(19):1969-77. doi: 10.1001/jama.2011.626.

PMID:
21586712
3.

Long-term outcome of microscopic esophagitis in chronic GERD patients treated with esomeprazole or laparoscopic antireflux surgery in the LOTUS trial.

Fiocca R, Mastracci L, Engström C, Attwood S, Ell C, Galmiche JP, Hatlebakk J, Junghard O, Lind T, Lundell L; LOTUS trial collaborators..

Am J Gastroenterol. 2010 May;105(5):1015-23. doi: 10.1038/ajg.2009.631. Epub 2009 Nov 10.

PMID:
19904246
4.

Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial.

Lundell L, Attwood S, Ell C, Fiocca R, Galmiche JP, Hatlebakk J, Lind T, Junghard O; LOTUS trial collaborators..

Gut. 2008 Sep;57(9):1207-13. doi: 10.1136/gut.2008.148833. Epub 2008 May 9.

Supplemental Content

Loading ...
Support Center